METROPOLITAN LIFE INSURANCE CO/NY - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 359 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$268,180
-10.0%
8,813
-0.8%
0.00%0.0%
Q3 2021$297,835
-18.6%
8,880
-3.2%
0.00%
-20.0%
Q2 2021$365,911
+35.3%
9,173
+52.5%
0.01%
+25.0%
Q1 2021$270,434
-22.5%
6,015
-2.6%
0.00%
-20.0%
Q4 2020$349,021
+16.6%
6,173
-2.1%
0.01%0.0%
Q3 2020$299,315
-21.4%
6,308
-2.3%
0.01%
-28.6%
Q2 2020$380,646
-10.3%
6,456
-28.1%
0.01%
-22.2%
Q1 2020$424,243
-24.1%
8,973
-3.1%
0.01%0.0%
Q4 2019$559,155
-1.0%
9,256
-1.8%
0.01%
-10.0%
Q3 2019$564,831
-4.5%
9,428
+2.5%
0.01%0.0%
Q2 2019$591,284
-22.6%
9,200
-2.3%
0.01%
-28.6%
Q1 2019$764,053
+47.1%
9,413
-2.0%
0.01%
+40.0%
Q4 2018$519,517
+4.5%
9,610
-0.3%
0.01%
+11.1%
Q3 2018$497,283
-99.9%
9,641
-1.9%
0.01%
+28.6%
Q2 2018$409,700,000
+0.7%
9,832
+6.6%
0.01%
+16.7%
Q1 2018$406,726,000
+87556.5%
9,227
+0.0%
0.01%0.0%
Q4 2017$464,000
-1.7%
9,224
-0.9%
0.01%
+100.0%
Q3 2017$472,000
+4.9%
9,312
+5.4%
0.00%0.0%
Q2 2017$450,000
+35.5%
8,837
+6.9%
0.00%
+50.0%
Q1 2017$332,000
-15.9%
8,2670.0%0.00%
-33.3%
Q4 2016$395,000
+24.6%
8,267
-4.3%
0.00%
+50.0%
Q3 2016$317,000
+50.2%
8,641
-4.6%
0.00%0.0%
Q2 2016$211,000
-41.9%
9,055
+0.9%
0.00%
-33.3%
Q1 2016$363,000
-34.7%
8,9730.0%0.00%
-25.0%
Q4 2015$556,0008,9730.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bellevue Group AG 9,930,245$396,117,0003.87%
Sicart Associates LLC 368,409$14,696,0003.50%
Camber Capital Management LP 2,000,000$79,780,0002.69%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 181,781$7,251,0001.91%
SECTOR GAMMA AS 263,488$10,511,0001.86%
Parkman Healthcare Partners LLC 136,380$5,440,0001.19%
Eversept Partners, LP 442,000$17,631,3801.18%
Affinity Asset Advisors, LLC 75,000$2,992,0001.07%
TANAKA CAPITAL MANAGEMENT INC 16,661$665,0000.90%
Sonora Investment Management, LLC 168,665$6,728,0000.88%
View complete list of IONIS PHARMACEUTICALS INC shareholders